Table 5.
Fine and Gray proportional subdistribution hazard model for ACR development in No Supplement and Pre group.
| Bivariate Analysis | Multivariable Analysis | |||
|---|---|---|---|---|
| Variables | sHR (95% CI) | p Value | sHR (95% CI) | p Value |
| Age >60 years | 1.03 (0.42–2.53) | 0.95 | 0.30 (0.12–0.77) | 0.01 |
| Sex (Male) | 1.02 (0.50–2.08) | 0.95 | ||
| Calculated MELD-Na >30 | 0.34 (0.08–1.43) | 0.14 | 0.28 (0.07–1.17) | 0.08 |
| Hepatocellular carcinoma | 0.95 (0.47–1.94) | 0.89 | ||
| Alcohol-related cirrhosis | 1.00 (0.48–2.06) | 0.99 | ||
| Vitamin D supplementation, Pre-transplant | 1.39 (0.67–2.87) | 0.38 | 1.05 (0.43–2.57) | 0.92 |
| Vitamin D sufficiency, Pre-transplant | 1.23 (0.59–2.59) | 0.58 | 1.38 (0.63–3.01) | 0.42 |
| Crossmatch for T or B cell positive | 0.94 (0.48–1.86) | 0.86 | ||
CI: confidence interval; sHR: subdistribution hazard ratio; MELD-Na: model for end-stage liver disease.